Open AccessRecent FDA approval of sofosbuvir and simeprevir. Implications for current HCV treatment
Author(s) -
Lin M. Valerie,
Chung Raymond
Publication year - 2014
Publication title -
clinical liver disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 14
ISSN - 2046-2484
DOI - 10.1002/cld.332
Subject(s) - simeprevir , ns5b , virology , sofosbuvir , ns3 , boceprevir , hepatitis c virus , telaprevir , protease , biology , imp dehydrogenase , virus , hepacivirus , enzyme , medicine , biochemistry , ribavirin , surgery , transplantation , mycophenolic acid
Watch a video presentation of this article Answer questions and earn CME
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom